All filters
Abstracts
Co-located treatment verus co-located care coordination to engage people who inject drugs in HCV care at a syringe service program: preliminary results from the accessible care randomized clinical trial
B. Eckhardt
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Simplified HCV treatment model in primary healthcare in the country of Georgia
E. Dolmazashvili
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Depist’c pharma an innovative outreach HCV screening project in pharmacy for drugs users and general population
A. Remy
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Slidesets
Update on Hepatitis Delta Therapy - Robert Gish MD, FAASLD, AGAF, FAST
Presented at:
International Workshop on HBV Cure 2020
Slidesets
Update on New Antiviral Targets –non –Capsid Inhibitors - Man-Fung YuenMBBS, MD, PhD, DSc
Presented at:
International Workshop on HBV Cure 2020
Slidesets
Update on New Immuno Modulators - Adam Gehring PhD
Presented at:
International Workshop on HBV Cure 2020
Slidesets
Update on Novel Combination Strategies - Marion Peters MD
Presented at:
International Workshop on HBV Cure 2020
Slidesets
Update on New Antiviral Targets Core Capsid Inhibitors (CpAMs) - Kosh Agarwal BMedSci (Hons) MD FRCP
Presented at:
International Workshop on HBV Cure 2020
Videos
Safety Monitoring for Investigational HBV Drugs and Discontinuation of HBV Therapy - Poonam Mishra MD, MPH, FAASLD
Presented at:
International Workshop on HBV Cure 2020
Videos
Toxicity in new and established HBV compounds - Jordan Feld, MD, MPH
Presented at:
International Workshop on HBV Cure 2020
Videos
How to interpret flares in HBV trials with novel agents - Pietro Lampertico, MD, PhD
Presented at:
International Workshop on HBV Cure 2020
Videos
Rationale for including immune tolerant and low viral load patients in new drug trials placeholder - Henry Lik Yeun Chan
Presented at:
International Workshop on HBV Cure 2020
Videos
Potential of new combinations to achieve functional cure for Chronic Hepatitis B - Fabien Zoulim, MD, PhD
Presented at:
International Workshop on HBV Cure 2020
Slidesets
Safety Monitoring for Investigational HBV Drugs and Discontinuation of HBV Therapy - Poonam Mishra MD, MPH, FAASLD
Presented at:
International Workshop on HBV Cure 2020
Slidesets
Toxicity in new and established HBV compounds - Jordan Feld, MD, MPH
Presented at:
International Workshop on HBV Cure 2020
Slidesets
How to interpret flares in HBV trials with novel agents - Pietro Lampertico, MD, PhD
Presented at:
International Workshop on HBV Cure 2020
Slidesets
Rationale for including immune tolerant and low viral load patients in new drug trials placeholder - Henry Lik Yeun Chan
Presented at:
International Workshop on HBV Cure 2020
Slidesets
Potential of new combinations to achieve functional cure for Chronic Hepatitis B - Fabien Zoulim, MD, PhD
Presented at:
International Workshop on HBV Cure 2020
Videos
Update on Novel Combination Strategies - Marion Peters MD
Presented at:
International Workshop on HBV Cure 2020
Videos
Update on New Immuno Modulators - Adam Gehring PhD
Presented at:
International Workshop on HBV Cure 2020
Videos
Update on New Antiviral Targets –non –Capsid Inhibitors - Man-Fung Yuen MBBS, MD, PhD, DSc
Presented at:
International Workshop on HBV Cure 2020
Videos
Update on New Antiviral Targets Core Capsid Inhibitors (CpAMs) - Kosh Agarwal BMedSci (Hons) MD FRCP
Presented at:
International Workshop on HBV Cure 2020
Videos
Update on Hepatitis Delta Therapy - Robert Gish MD, FAASLD, AGAF, FAST
Presented at:
International Workshop on HBV Cure 2020